Walter M. Stadler to CD27 Ligand
This is a "connection" page, showing publications Walter M. Stadler has written about CD27 Ligand.
Connection Strength
0.033
-
First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70. Cancer Chemother Pharmacol. 2016 Jan; 77(1):155-62.
Score: 0.033